Viral or non-viral angiogenesis gene transfer-New answers to old questions

Cardiovascular Research

Volumn 73, Issue 3, 2007, Pages 443-445

  Nikol, Sigrid ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOSOME; PLASMID DNA; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ARTERY DISEASE; BIOSAFETY; CAPILLARY; CLINICAL TRIAL; DOSE RESPONSE; EDITORIAL; FAMILY THERAPY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HEART FUNCTION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LOCAL THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLASMID; PRIORITY JOURNAL; SAFETY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; CLINICAL TRIALS, PHASE II; CORONARY DISEASE; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 33846043523     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.12.005     Document Type: Editorial

References (19)

1. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93 (1994) 662-670
2. Wiley Website; http://www.wiley.co.uk/genmed/clinical/.
3. Yla-Herttuala S., and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9 (2003) 694-701
4. 165) is efficient for therapeutic angiogenesis in pigs. Acta Physiol Scand 176 (2002) 151-159
5. Laitinen M., Makinen K., Manninen H., Matsi P., Kossila M., Agrawal R.S., et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 9 (1998) 1481-1486
6. Hedman M., Hartikainen J., Syvanne M., Stjernvall J., Hedman A., Kivela A., et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107 (2003) 2677-2683
7. Makinen K., Manninen H., Hedman M., Matsi P., Mussalo H., Alhava E., et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 61 (2002) 127-133
8. Hao X., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., Brodin L.A., et al. Myocardial angiogenesis after plasmid or adenoviral VEGF-A165 gene transfer in a rat myocardial infarction model. Cardiovasc Res 73 (2007) 481-487
9. Armeanu S., Pelisek J., Krausz E., Fuchs A., Groth D., Curth R., et al. Optimization of non-viral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther 1 (2000) 366-375
10. Pelisek J., Engelmann M.G., Golda A., Fuchs A., Armeanu S., Shimizu M., et al. Optimisation of non-viral transfection: variables influencing liposome-mediated gene transfer in proliferating versus quiescent cells in culture and in vivo using a porcine restenosis model. J Mol Med 80 (2002) 724-736
11. Siddiqui A.J., Blomberg P., Wardell E., Hellgren I., Eskandarpour M., Islam K.B., et al. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 310 (2003) 1002-1009
12. Gyongyosi M., Khorsand A., Zamini S., Sperker W., Strehblow C., Kastrup J., et al. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 112 (2005) I157-I165
13. Kawamoto A., Murayama T., Kusano K., Li M., Tkebuchava T., Shintani S., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
14. Grines C.L., Watkins M.W., Helmer G., Penny W., Brinker J., Marmur J.D., et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 (2002) 1291-1297
15. Grines C., Rubanyi G.M., Kleiman N.S., Marrott P., and Watkins M.W. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol 92 (2003) 24N-31N [suppl]
16. Stewart D.J., Hilton J.D., Arnold J.M., Gregoire J., Rivard A., Archer S.L., et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther 13 (2006) 1503-1511
17. Kastrup J., Jorgensen E., Ruck A., Tagil K., Glogar D., Ruzyllo W., et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol 45 (2005) 982-988
18. Rajagopalan S., Mohler III E.R., Lederman R.J., Mendelsohn F.O., Saucedo J.F., Goldman C.K., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108 (2003) 1933-1938
19. Nikol S, Baumgartner I, Van Belle E, Diehm C, Visona A, Capogrossi MC, et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia (submitted for publication).